Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 29 (4), 221-7

Assessment of Developmental Toxicants Using Human Embryonic Stem Cells


Assessment of Developmental Toxicants Using Human Embryonic Stem Cells

Eui-Ju Hong et al. Toxicol Res.


Embryonic stem (ES) cells have potential for use in evaluation of developmental toxicity because they are generated in large numbers and differentiate into three germ layers following formation of embryoid bodies (EBs). In earlier study, embryonic stem cell test (EST) was established for assessment of the embryotoxic potential of compounds. Using EBs indicating the onset of differentiation of mouse ES cells, many toxicologists have refined the developmental toxicity of a variety of compounds. However, due to some limitation of the EST method resulting from species-specific differences between humans and mouse, it is an incomplete approach. In this regard, we examined the effects of several developmental toxic chemicals on formation of EBs using human ES cells. Although human ES cells are fastidious in culture and differentiation, we concluded that the relevancy of our experimental method is more accurate than that of EST using mouse ES cells. These types of studies could extend our understanding of how human ES cells could be used for monitoring developmental toxicity and its relevance in relation to its differentiation progress. In addition, this concept will be used as a model system for screening for developmental toxicity of various chemicals. This article might update new information about the usage of embryonic stem cells in the context of their possible ability in the toxicological fields.

Keywords: Developmental toxicity; Differentiation; Embryoid body; Embryonic stem cells.


Fig. 1.
Fig. 1.. Schematic overview of the EST method. The figure illustrates the principle and the endpoints of the EST method to assess the developmental toxic chemicals using permanent cell lines: 3T3 fibroblast and mouse ES cells.
Fig. 2.
Fig. 2.. Scheme for differentiation-related endpoints using developmental toxicants.

Similar articles

See all similar articles

Cited by 4 PubMed Central articles


    1. Höfer T.I., Gerner I., Gundert-Remy U., Liebsch M., Schulte A., Spielmann H., Vogel R., Wettig K. Animal testing and alternative approaches for the human health risk assessment under the proposed new European chemicals regulation. Arch. Toxicol. (2004);78:549–564. doi: 10.1007/s00204-004-0577-9. - DOI - PubMed
    1. Yamanaka S., Li J., Kania G, Elliott S, Wersto R.P., Van Eyk J., Wobus A.M., Boheler J.R. Pluripotency of embryonic stem cells. Cell Tissue Res. (2008);331:5–22. doi: 10.1007/s00441-007-0520-5. - DOI - PubMed
    1. Heuer J., Bremer S., Pohl I., Spielmann H. Development of an in vitro embryotoxicity test using murine embryonic stem cell cultures. Toxicol. In Vitro. (1993);7:551–556. doi: 10.1016/0887-2333(93)90064-C. - DOI - PubMed
    1. Scholz G., Pohl I., Genschow E., Klemm M., Spielmann H. Embryotoxicity screening using embryonic stem cells in vitro: correlation to in vivo teratogenicity. Cells Tissues Organs. (1999);165:203–211. doi: 10.1159/000016700. - DOI - PubMed
    1. Genschow E., Scholz G., Brown N.A., Piersma A.H., Brady M., Clemann N., Huuskonen H., Paillard F., Bremer S., Spielmann H. [Development of prediction models for three in vitro embryotoxicity tests which are evaluated in an ECVAM validation study]. ALTEX. (1999);16:73–83. - PubMed